We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Compliance With Metformin

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00018616
First Posted: July 5, 2001
Last Update Posted: September 23, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
VA Office of Research and Development
  Purpose
This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.

Condition Intervention Phase
Diabetes Behavioral: MEMS caps Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Improving Compliance With Metformin

Resource links provided by NLM:


Further study details as provided by VA Office of Research and Development:

Enrollment: 79
Study Start Date: October 1999
Study Completion Date: January 2005
Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1 Behavioral: MEMS caps

Detailed Description:
The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Metformin has been prescribed
  • Willing to use medication containers with MEMS caps
  • Capable of giving informed consent

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018616


Locations
United States, Connecticut
VA Connecticut Health Care System (West Haven)
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Principal Investigator: Marc I. Rosen, MD VA Connecticut Health Care System (West Haven)
  More Information

Responsible Party: Rosen, Marc - Principal Investigator, Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018616     History of Changes
Other Study ID Numbers: MHBS-047-98F
First Submitted: July 3, 2001
First Posted: July 5, 2001
Last Update Posted: September 23, 2009
Last Verified: September 2009

Keywords provided by VA Office of Research and Development:
compliance
MEMS
metformin

Additional relevant MeSH terms:
Metformin
Hypoglycemic Agents
Physiological Effects of Drugs